Traws Pharma, Inc. Shares Issued
Traws Pharma, Inc. (TRAW) had Shares Issued of 15.26 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-14
- 2026-06-30: Common Stock, Shares, Issued 15.26M shares.
- 2026-03-31: Common Stock, Shares, Issued 10.16M shares.
- 2025-12-31: Common Stock, Shares, Issued 9.07M shares.
- 2025-09-30: Common Stock, Shares, Issued 7.13M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 15.26M shares 10-Q · filed 2026-08-14 | |
| 2026-03-31 | 10.16M shares 10-Q · filed 2026-05-15 | |
| 2025-12-31 | 9.07M shares 10-Q · filed 2026-08-14 | |
| 2025-09-30 | 7.13M shares 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 7.07M shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 5.08M shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 3.65M shares 10-K · filed 2026-04-15 | |
| 2024-09-30 | 3.03M shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 25.31M shares 10-Q · filed 2024-08-15 | |
| 2024-03-31 | 21.09M shares 10-Q · filed 2024-05-15 | |
| 2023-12-31 | 840.25K shares 10-K · filed 2025-03-31 | 21.00M shares 10-K · filed 2024-04-01 |
| 2023-09-30 | 21.00M shares 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 20.98M shares 10-Q · filed 2023-08-14 | |
| 2023-03-31 | 20.97M shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 20.93M shares 10-K · filed 2024-04-01 | |
| 2022-09-30 | 20.93M shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 20.90M shares 10-Q · filed 2022-08-15 | |
| 2022-03-31 | 20.90M shares 10-Q · filed 2022-05-13 | |
| 2021-12-31 | 20.90M shares 10-K · filed 2023-03-30 | |
| 2021-09-30 | 20.89M shares 10-Q · filed 2021-11-15 | |
| 2021-06-30 | 15.78M shares 10-Q · filed 2021-08-16 | |
| 2021-03-31 | 236.69M shares 10-Q · filed 2021-05-17 | |
| 2020-12-31 | 12.40M shares 10-K · filed 2022-03-21 | 185.94M shares 10-K · filed 2021-03-18 |
| 2020-09-30 | 184.55M shares 10-Q · filed 2020-11-16 | |
| 2020-06-30 | 174.18M shares 10-Q · filed 2020-08-12 | |
| 2020-03-31 | 167.42M shares 10-Q · filed 2020-05-15 | |
| 2019-12-31 | 111.17M shares 10-K · filed 2021-03-18 | |
| 2019-09-30 | 8.20M shares 10-Q · filed 2019-11-12 | |
| 2019-06-30 | 6.00M shares 10-Q · filed 2019-08-14 | |
| 2019-03-31 | 5.90M shares 10-Q · filed 2019-05-15 | |
| 2018-12-31 | 5.67M shares 10-K · filed 2020-03-27 | |
| 2018-09-30 | 5.67M shares 10-Q · filed 2018-11-14 | |
| 2018-06-30 | 85.11M shares 10-Q · filed 2018-08-14 | |
| 2018-03-31 | 19.43M shares 10-Q · filed 2018-05-15 | |
| 2017-12-31 | 718.08K shares 10-K · filed 2019-04-01 | 10.77M shares 10-K · filed 2018-03-16 |
| 2017-09-30 | 9.85M shares 10-Q · filed 2017-11-09 | |
| 2017-06-30 | 9.85M shares 10-Q · filed 2017-08-14 | |
| 2017-03-31 | 6.77M shares 10-Q · filed 2017-05-15 | |
| 2016-12-31 | 6.76M shares 10-K · filed 2018-03-16 | |
| 2016-09-30 | 6.76M shares 10-Q · filed 2016-11-14 | |
| 2016-06-30 | 2.74M shares 10-Q · filed 2016-08-15 | |
| 2016-03-31 | 27.40M shares 10-Q · filed 2016-05-11 | |
| 2015-12-31 | 2.55M shares 10-K · filed 2017-03-29 | 25.46M shares 10-K · filed 2016-03-28 |
| 2015-09-30 | 23.68M shares 10-Q · filed 2015-11-12 | |
| 2015-06-30 | 21.74M shares 10-Q · filed 2015-08-13 | |
| 2015-03-31 | 21.70M shares 10-Q · filed 2015-05-15 | |
| 2014-12-31 | 21.70M shares 10-K · filed 2016-03-28 | |
| 2014-09-30 | 21.69M shares 10-Q · filed 2014-11-14 | |
| 2014-06-30 | 21.67M shares 10-Q · filed 2014-08-14 | |
| 2014-03-31 | 21.64M shares 10-Q · filed 2014-05-15 | |
| 2013-12-31 | 21.47M shares 10-K · filed 2015-03-30 | |
| 2013-09-30 | 21.41M shares 10-Q · filed 2013-11-14 | |
| 2013-06-30 | 2.61M shares 10-Q · filed 2013-09-06 | |
| 2012-12-31 | 2.61M shares 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |